Whalerock Point Partners, LLC Abb Vie Inc. Transaction History

Whalerock Point Partners, LLC

$353 Million
Q1 2024

A detailed history of Whalerock Point Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Whalerock Point Partners, LLC holds 11,064 shares of ABBV stock, worth $1.85 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

11,064

Previous 10,914 1.37%

Holding current value

$1.85 Million

Previous $1.69 Million 19.1%

% of portfolio

0.57%

Previous 0.54%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $23,973 - $27,315	150 Added 1.37%	11,064 $2.01 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $64,123 - $74,232	480 Added 4.6%	10,914 $1.63 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $10,865 - $13,521	-82 Reduced 0.78%	10,434 $1.41 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $36,875 - $42,467	255 Added 2.49%	10,516 $1.68 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $4,979 - $5,971	36 Added 0.35%	10,261 $1.66 Million

Q3 2022 Nov 16, 2022	BUY	$134.21 - $153.93 $1.19 Million - $1.36 Million	8,853 Added 645.26%	10,225 $1.37 Million
Q3 2022 Nov 15, 2022	SELL	$134.21 - $153.93 $1.01 Million - $1.16 Million	-7,528 Reduced 84.58%	1,372 $1.37 Billion
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $35,368 - $44,964	257 Added 2.97%	8,900 $1.36 Million
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $42,972 - $54,372	400 Added 4.85%	8,643 $1.17 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $126,828 - $143,969	1,192 Added 16.91%	8,243 $889,000
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $5,260 - $5,860	50 Added 0.71%	7,051 $794 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $92,070 - $101,358	900 Added 14.75%	7,001 $757,000
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $454,124 - $613,116	5,642 Added 1229.19%	6,101 $654,000
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $362,110 - $424,998	-4,215 Reduced 90.18%	459 $40,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $38,700 - $58,674	600 Added 14.73%	4,674 $356,000
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $7,213 - $9,025	-100 Reduced 2.4%	4,074 $361,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $7,872 - $9,465	-125 Reduced 2.91%	4,174 $316,000
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $28,850 - $33,955	374 Added 9.53%	4,299 $346,000
Q2 2018 Mar 04, 2019	SELL	$89.78 - $106.23 $33,577 - $39,730	-374 Reduced 8.7%	3,925 $364,000
Q1 2018 Apr 05, 2018	SELL	$92.01 - $123.21 $6,900 - $9,240	-75 Reduced 1.71%	4,299 $407,000
Q3 2017 Oct 31, 2017	BUY	$69.85 - $89.22 $305,523 - $390,248	4,374	4,374 $388,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whalerock Point Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whalerock Point Partners, LLC with notifications on news.

Account

Whalerock Point Partners, LLC Abb Vie Inc. Transaction History